About this trial
The purpose of this research is to examine the effects that functional electrical stimulation (FES) therapy has on the way the arms, brain and spinal cord work. The study team wants to understand what recovery looks like in persons with a spinal cord injury (SCI) or peripheral nerve injury (PNI) using the MyndMove (MyndTec Inc., Ontario, Canada) therapy system. This type of therapy uses stimulation to help people with SCI and other neurological conditions to perform common tasks, work out, or strengthen muscles.
Eligibility criteria
Qualifiers
Traumatic spinal cord injury (SCI): neurological level at or above T1 spinal cord level; AIS A, B, C or D impairment grade
Group 1 (Acute SCI): Deemed medically stable by medical practitioner, less than 6 months post-injury.
Group 2 (Chronic SCI): More than 6 months post-injury.
Peripheral nerve injury (PNI), with or without SCI, who are pre- or post- upper extremity (UE) nerve transfer surgery
Disqualifiers
Traumatic brain injury, stroke, multiple sclerosis, or other disorders that could affect neuromotor function.
Severe spasticity that could prevent the study protocol as determined by the investigator.
Major executive dysfunction, dementia, depression, neurocognitive impairments, or other major medical co-morbidities.
Has contraindications for transcutaneous stimulation using FES such as breakdown of skin in the area that will come into contact with electrodes, thrombosis, or skin disease
Trial design
Treatments tested in this trial
- MyndMove Short Term Therapy
- Conventional Short Term Therapy
- MyndMove Long Term Therapy